Li Wei, Zhu Kaili, Ma Zhongqiang, Wang Tao
Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
Xuzhou Medical University, Xuzhou, 221000, China.
Endocrine. 2025 Mar;87(3):1216-1223. doi: 10.1007/s12020-024-04100-y. Epub 2024 Nov 23.
Previous investigations have assessed the connection between vitamin D deficiency and an increased risk of gestational diabetes mellitus (GDM); however, the findings remain inconsistent. The purpose of this study was to investigate the causal relationship between 25-hydroxyvitamin D (25OHD) levels and GDM.
Summary statistics data from genome-wide association studies (GWASs) were used to perform a bidirectional two-sample Mendelian randomization (MR) study. A total of 417,580 Europeans from the UK Biobank provided summary statistics data for 25OHD. The tenth data release of the FinnGen study provided the data for GDM, comprising 14,718 cases and 215,592 controls. For the univariate MR (uvMR) investigations, we employed the inverse variance weighted (IVW) method as our major analytical approach. Multiple sensitivity analyses were performed to evaluate the robustness of the results. Moreover, multivariate MR (mvMR) studies were conducted to account for potential confounding variables, including obesity, insulin resistance, and lipid traits.
In the forward MR study, uvMR analysis did not provide evidence supporting a causal effect of 25OHD levels on the risk of GDM [IVW odds ratio (OR): 1.07, 95% confidence interval (CI): 0.95 to 1.19, p = 0.273]. After adjusting for obesity, fasting insulin levels, and lipid traits, the findings from the mvMR analysis aligned with those of the uvMR analysis. In the reverse MR study, uvMR analysis indicated that GDM had no causal effect on serum 25OHD levels (IVW β = -0.003, p = 0.804), and the robustness of this finding was confirmed in the mvMR study.
Our MR research revealed no causal effect of serum 25OHD levels on GDM, suggesting that 25OHD deficiency does not correlate with an increased risk of GDM. Furthermore, our reverse analysis revealed no causal effect of GDM on 25OHD levels.
以往的研究评估了维生素D缺乏与妊娠期糖尿病(GDM)风险增加之间的联系;然而,研究结果仍不一致。本研究的目的是探讨25-羟基维生素D(25OHD)水平与GDM之间的因果关系。
利用全基因组关联研究(GWAS)的汇总统计数据进行双向两样本孟德尔随机化(MR)研究。来自英国生物银行的417,580名欧洲人提供了25OHD的汇总统计数据。芬兰基因研究的第十次数据发布提供了GDM的数据,包括14,718例病例和215,592例对照。对于单变量MR(uvMR)研究,我们采用逆方差加权(IVW)方法作为主要分析方法。进行了多项敏感性分析以评估结果的稳健性。此外,还进行了多变量MR(mvMR)研究,以考虑潜在的混杂变量,包括肥胖、胰岛素抵抗和脂质特征。
在前瞻性MR研究中,uvMR分析未提供证据支持25OHD水平对GDM风险有因果效应[IVW比值比(OR):1.07,95%置信区间(CI):0.95至1.19,p = 0.273]。在调整肥胖、空腹胰岛素水平和脂质特征后,mvMR分析的结果与uvMR分析的结果一致。在反向MR研究中,uvMR分析表明GDM对血清25OHD水平没有因果效应(IVWβ = -0.003,p = 0.804),并且该结果在mvMR研究中得到了证实。
我们的MR研究表明血清25OHD水平对GDM没有因果效应,这表明25OHD缺乏与GDM风险增加无关。此外,我们的反向分析表明GDM对25OHD水平没有因果效应。